NLAB Saga®

NLAB Saga® is a perfectly spherical, fully porous silica with superior mechanical stability and exceptional
chemical stability at high and low pH, making it an
optimum choice for large scale purification of peptides.


Nanologica is a Swedish nanotechnology company, world-leading in the development of nanoporous silica particles for purification by chromatography. Chromatography is a widely used technique for separating components in a mixture. We are active mainly in preparative chromatography,
where we provide input goods to pharmaceutical manufacturers for purification of drugs during production.

Our mission is to increase the availability of cost-effective drugs, enabling more patients around the world access to vital treatments for diabetes and obesity. 

Nanologica’s products have been specially developed for the purification of peptide drugs, such as insulin and GLP-1 analogues,
and are produce according to a proprietary production method. Due to effective purification and a long lifetime for the products,
they can increase productivity and reduce costs for pharmaceutical manufacturers.

Nanologica operates in a global niche market that is growing as a result of an increased demand for drugs for treating diabetes and obesity.

The company is headquartered in Södertälje and Nanologica’s share (NICA) is listed for trading on Nasdaq Stockholm Main Market.


Year-End Report 2023 Nanologica AB (publ)

FINANCIAL SUMMARY Net sales for the fourth quarter amounted to TSEK 75 (674) and for the full year to TSEK 1,443 (1,555) The operating loss for the quarter amounted to TSEK -35,638 (-13,251) and for the full year to TSEK -69,963 (-50,850). Operating loss was affected by write-downs of tangible and intangible assets during the

Read more »

Listen to our team talk about Nlab Saga®

Play Video about Katarina Alenäs – SVP Chromatography

Interview with Katarina Alenäs,
SVP Chromatography

Play Video

Interview with Olga Krivosheeva, Ph.D.
Application Project Manager 

Play Video

Interview with Chunfang Zhou, Ph.D.
Sales Manager China

Nanologica is a public company listed for trade on Nasdaq Stockholm Main Market. For information regarding financial reports, press releases, presentations and share holder information, please visit our investor relations section.

Presentation of Nanologica

For more videos presentations of the company and of interim reports, please refer to Investor Relations.

Company presentation made by CEO Andreas Bhagwani in June, 2023.

Investor Pitch Deck September 2023.

Please contact us at for more information.